rank,ticker,company_name,ai_score,sentiment,recommendation,catalysts,risks,certainty,articles_count,quant_alpha,current_price,price_timestamp,entry_zone_low,entry_zone_high,target_conservative,target_aggressive,stop_loss,fundamental_adjustment,quarterly_earnings_growth_yoy,annual_earnings_growth_yoy,profit_margin_pct,debt_to_equity,is_profitable,net_worth_positive,financial_health_status,headline,reasoning
1,SYNGENE,SYNGENE INTERNATIONAL LIMITED,66.6,bullish,HOLD,"clinical_trial_milestone, expansion, sector_momentum","Near-term profitability pressured by depreciation costs from new biologics facility, Inventory adjustment headwinds with large molecule customer continuing for next few quarters, Q2 net profit down 37% YoY to ₹67cr despite 2% revenue growth, Oversold technicals (RSI 37.8) with downtrend (-6.7% 10d momentum), Price below both 20DMA and 50DMA indicating weak momentum",65,1,40.3,616.30,2025-11-09T20:16:30.858439,610.14,616.30,640.95,665.60,591.65,+5.36,14.53,,9.91,0.12,TRUE,TRUE,healthy,"Syngene eyes growth tailwinds from global trial wins, biotech funding recovery: CEO","Syngene secured its first global Phase 3 clinical trial (significant milestone) and CEO signals early VC funding recovery in US biotech, providing medium-term growth tailwinds. However, near-term prof"
2,TRIDENT,TRIDENT LIMITED,56.2,neutral,HOLD,expansion,"Wrong ticker - news is about Trident Realty (real estate), not TRIDENT (textiles NSE ticker), Complete sector mismatch - real estate company vs textile/paper manufacturer, News has zero relevance to the actual stock being analyzed, Negative technicals - price below 20/50 DMA, negative 10d momentum, RSI neutral at 52 but downtrend intact",95,1,53.3,28.05,2025-11-09T19:55:11.570101,27.63,28.19,28.75,29.45,27.35,+7.84,89.83,5.83,8.20,0.35,TRUE,TRUE,healthy,"Trident Realty targets ₹1,200 crore revenue from sale of 199 plots at Panchkula","CRITICAL ERROR: This news is about 'Trident Realty' (a real estate developer), NOT the NSE-listed 'TRIDENT' (textiles/paper manufacturer, ticker TRIDENT.NS). The ₹1,200cr plot sale has ZERO impact on "
3,ASTRAL,ASTRAL LIMITED,54.8,bullish,HOLD,"technical_breakout, analyst_recommendation","Quarterly earnings down -32.6% Y-o-Y indicating fundamental weakness, Revenue decline of -18.4% Q-o-Q shows deteriorating business performance, Recommendation based solely on technical setup without fundamental catalyst, Profit margin at 5.96% is low, limiting upside potential, No specific news event - purely analyst recommendation risk",45,1,57.4,1557.30,2025-11-09T20:00:12.127624,1533.94,1565.09,1596.23,1635.17,1518.37,-1.02,-32.64,,5.96,,,,moderate,Market Trading Guide: Buy Astral and Angel One on Monday for up to 15% gains. Here’s why ,"Economic Times article recommends buying ASTRAL with 3.4% upside target. However, this is purely a technical recommendation without any fundamental catalyst. The recent quarterly results show severe d"
4,RELIANCE,RELIANCE INDUSTRIES LIMITED,43.2,neutral,HOLD,,"News is CSR donation, not business catalyst, No impact on revenue/earnings/operations, Historical RELIANCE predictions show 0% success rate, News lacks any trading relevance for swing setup",90,1,51.6,1478.00,2025-11-09T20:10:45.852216,1455.83,1485.39,1514.95,1551.90,1441.05,+4.46,78.32,,11.08,,,,healthy,Reliance Chairman Mukesh Ambani donates  ₹15 crore to Guruvayur Devaswom for new hospital project in,"While the ₹15 crore donation to Guruvayur Devaswom is confirmed with high certainty (tier-1 source, specific amount), this is purely a CSR/philanthropic activity with zero business impact. The donatio"
